Grace Bio-Labs Collaborative Research Corner
Enabling Cell-based Assays and Translation to Personalized Medicine
Cell-based assays have expanded in use, and reduced in sample requirements over the past decade, driven by technologies that have improved the culture and monitoring of cell functions on a miniature scale. One of our partners, Microstem Inc., based in San Diego, CA, is an example of an early stage reagent development company that approached Grace Bio-Labs for technical solutions to supply their system for cell-based assays. The MicroMatrix(tm) system from Microstem consists of an array of various extracellular matrices printed onto a hydrogel-coated microscope slide. The system enables parallel culture of cells in the presence of hundreds to thousands of fully defined extracellular matrices in order to determine the precise cellular microenvironment that affects cell behavior and functions, including adhesion, proliferation and differentiation.
“The advantage of our system is the use of defined human matrices in a miniaturized platform, which allows researchers to study a variety of cellular microenvironments in parallel with high reproducibility. This platform is particularly useful when conducting studies using primary cells, such as stem cell and tumor cells” says Marie Zhang, COO at Microstem. “Many of the matrices provided by other vendors are derived from complex biological material which can vary from lot-to-lot and frequently is not xeno-free,” explains Marie.
News and Events
Grace Bio-Labs is pleased to again sponsor the Annual Global RPPA Workshop | October 24-25 | Paris, France
We will be presenting “A Proteomic Profiling System for Near IR Fluorescent Multi-Color Multiplex RPPA Microarrays”Learn More
We are proud to announce that Grace Bio-Labs has entered into a Product LIcensing agreement withTheranostics Health, Inc. for the manufacture and market distribution of Theranostic’s novel tissue preservative, TheraLin®Learn More